The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma: A Morphologic and Molecular Genetic Analysis
Explore this paper's citation graph
Summary
The clonality of 6 cases of high-grade serous carcinomas that were closely associated with atypical proliferative serous (borderline) tumors and invasive low-grade micropapillary serous cancers was determined.
- Type
- article
- Published
- 2007-07-01
- Cited by
- 152
- References
- 17
- OpenAlex
- https://openalex.org/W2009985804
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:37905442
Keywords
Serous fluid, Serous carcinoma, Pathology, Medicine, Carcinoma
References
- Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
- Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases.
- Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors
- Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation
- Geographical Variations in TP53 Mutational Spectrum in Ovarian Carcinomas
- Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.
- Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
- Early de novo ovarian carcinoma. A study of fourteen cases
- Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.
- Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
- Diverse tumorigenic pathways in ovarian serous carcinoma.
- P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.
- p53 mutation is a common genetic event in ovarian carcinoma.
- Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges
- Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome.
- TP53 and ovarian cancer
- Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential
Cited by
- Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs.
- Laparoscopic restaging of borderline ovarian tumours (BLOT): a retrospective study of 142 cases.
- KRAS (but not BRAF) mutations in ovarian serous borderline tumor are associated with recurrent low-grade serous carcinoma
- Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms
- BRAF mutational analysis in ovarian tumors: recent perspectives
- Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study
- Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series
- Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report
- The Origin of Ovarian Carcinomas: A Unifying Hypothesis
- Molecular Pathogenesis and Extraovarian Origin of Epithelial Ovarian Cancer. Shifting the Paradigm
- Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma: Report of a Series of Cases of an Unusual Phenomenon
- High‐grade serous carcinoma arising in a low‐grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23‐year‐old woman
- Multiple cutaneous monoclonal B‐cell proliferations as harbingers of systemic angioimmunoblastic T‐cell lymphoma
- Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
- Research developments on the histopathology and prognostic predictors of serous borderline tumor of ovary
- Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications
- Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement.
- Low-Grade Serous Tumors of Ovary
- Ovarian carcinoma pathology and genetics: recent advances.
- Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates
Related papers
- Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome.
- Relationship of Preoperative Serous CA125 with Clinicopathological Features and Prognosis in Patients with Epithelial Ovarian Cancer
- Mixed serous—endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinoma
- Micropapillary Serous Carcinoma: The Solution to the Ovarian Borderline Tumor Conundrum
- Clinicopathologic and molecular features of paired cases of metachronous ovarian serous borderline tumor and subsequent serous carcinoma
- High‐grade ovarian serous carcinoma exhibits significantly higher p16 expression than low‐grade serous carcinoma and serous borderline tumour
- 37. Retrospective review of 27 cases reported as low grade serous ovarian carcinoma
- Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor.
- Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
- The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated with Differentiation and Survival in Ovarian Cancer